ATE159983T1 - Monoklonaler antikörper gegen htlv-iii (stamm mn) - Google Patents

Monoklonaler antikörper gegen htlv-iii (stamm mn)

Info

Publication number
ATE159983T1
ATE159983T1 AT91110884T AT91110884T ATE159983T1 AT E159983 T1 ATE159983 T1 AT E159983T1 AT 91110884 T AT91110884 T AT 91110884T AT 91110884 T AT91110884 T AT 91110884T AT E159983 T1 ATE159983 T1 AT E159983T1
Authority
AT
Austria
Prior art keywords
htlv
iiimn
binding
monoclonal antibody
cells
Prior art date
Application number
AT91110884T
Other languages
English (en)
Inventor
Yasuyuki Eda
Kiyoshi Osatomi
Kouichi Shiosaki
Sachio Tokiyoshi
Shuzo Matsushita
Toshio Hattori
Kiyoshi Takatsuki
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE159983T1 publication Critical patent/ATE159983T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91110884T 1990-07-02 1991-07-01 Monoklonaler antikörper gegen htlv-iii (stamm mn) ATE159983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17507590 1990-07-02
JP2188300A JP2989862B2 (ja) 1990-07-02 1990-07-16 モノクローナル抗体

Publications (1)

Publication Number Publication Date
ATE159983T1 true ATE159983T1 (de) 1997-11-15

Family

ID=26496454

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91110884T ATE159983T1 (de) 1990-07-02 1991-07-01 Monoklonaler antikörper gegen htlv-iii (stamm mn)

Country Status (5)

Country Link
EP (1) EP0465979B1 (de)
JP (1) JP2989862B2 (de)
AT (1) ATE159983T1 (de)
AU (1) AU641026B2 (de)
DE (1) DE69128108T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004574A1 (en) * 1991-08-22 1994-03-03 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
WO1993004090A1 (en) * 1991-08-22 1993-03-04 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
WO1994015969A1 (fr) * 1993-01-14 1994-07-21 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anticorps anti-vih recombine et sa preparation
KR100266554B1 (ko) * 1993-01-14 2000-09-15 사꼬 미쓰오 재조합항-hiv항체및그의제조방법
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US6193982B1 (en) 1995-04-27 2001-02-27 The United States Of America As Represented By The Department Of Health & Human Services Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
US5843882A (en) 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
ATE369427T1 (de) 2001-03-22 2007-08-15 Us Health Glykosylierungsresistente cyanovirine und damit verbundene konjugate, zusammensetzungen, nukleinsäuren, vektoren, wirtszellen, herstellungsverfahren sowie verfahren zur verwendung nichtglykosylierter cyanovirine
CN102066418A (zh) * 2007-11-19 2011-05-18 国立大学法人熊本大学 抗hiv单克隆抗体
JP7297220B2 (ja) 2019-10-29 2023-06-26 国立大学法人 熊本大学 抗ｈｉｖ活性を有するｃｄ４ミミック化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122237T1 (de) * 1987-05-29 1995-05-15 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
PT94276A (pt) * 1989-06-05 1991-02-08 Anticorpo monoclonal capaz de neutralizar o prototipo mn de hiv

Also Published As

Publication number Publication date
DE69128108D1 (de) 1997-12-11
JPH04152893A (ja) 1992-05-26
EP0465979B1 (de) 1997-11-05
AU641026B2 (en) 1993-09-09
JP2989862B2 (ja) 1999-12-13
DE69128108T2 (de) 1998-03-26
EP0465979A1 (de) 1992-01-15
AU8010791A (en) 1992-01-02

Similar Documents

Publication Publication Date Title
Ljunggren et al. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Nara et al. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses
Nara et al. Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies
ATE159983T1 (de) Monoklonaler antikörper gegen htlv-iii (stamm mn)
AU632475B2 (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
ATE122237T1 (de) Hiv-1 neutralisierende monoklonale antikörper.
Cavacini et al. Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals
WO1989006276A2 (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
DE69332911D1 (de) Rekombinanter humanisierter Antikörper gegen menschlichen Immunschwächevirus
EP0470184A4 (en) Antibodies specific for cd4-binding domain of hiv
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
Pyle et al. Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)
EP1016671A3 (de) Menschliche, monoklonale Antikörper gegen das transmembrane Glycoprotein (gp41) des HIV-1, und verwandte Peptide
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
Broliden et al. Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies
AU659839B2 (en) Human immunodeficiency virus-related immune preparation
Nishino et al. Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells
CA2046016A1 (en) Hiv monoclonal antibody
CA2160696A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
Benjouad et al. Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type‐1 envelope glycoprotein
ATE128733T1 (de) Monoklonale antikörper gegen hiv gp120.
US5562905A (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0250128A3 (de) Von AIDS-Patienten isoliertes Virus
LONDOS-GAGLIARDI et al. Antibodies directed against a variable and neutralizable region of the HTLV-I envelope surface glycoprotein.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties